These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19619416)

  • 1. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.
    Lawrence WS; Hardcastle JM; Brining DL; Weaver LE; Ponce C; Whorton EB; Peterson JW
    Comp Med; 2009 Jun; 59(3):257-65. PubMed ID: 19619416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.
    Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL
    Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.
    Gutting BW; Marchette D; Sherwood R; Andrews GA; Director-Myska A; Channel SR; Wolfe D; Berger AE; Mackie RS; Watson BJ; Rukhin A
    J Theor Biol; 2013 Jul; 329():20-31. PubMed ID: 23567649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).
    Lever MS; Stagg AJ; Nelson M; Pearce P; Stevens DJ; Scott EA; Simpson AJ; Fulop MJ
    Int J Exp Pathol; 2008 Jun; 89(3):171-9. PubMed ID: 18460069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of human anthrax: the Quest for the Holy Grail.
    Goossens PL
    Mol Aspects Med; 2009 Dec; 30(6):467-80. PubMed ID: 19665473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with
    Dawson DG; Bower KA; Burnette CN; Holt RK; Swearengen JR; Dabisch PA; Scorpio A
    J Am Assoc Lab Anim Sci; 2017 Nov; 56(6):792-801. PubMed ID: 29256375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores.
    Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA
    PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Response Modeling for Inhalational Anthrax in Rabbits Following Single or Multiple Exposures.
    Gutting BW; Rukhin A; Marchette D; Mackie RS; Thran B
    Risk Anal; 2016 Nov; 36(11):2031-2038. PubMed ID: 26889937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.
    Yee SB; Dyer DN; Twenhafel NA; Pitt ML
    Comp Med; 2013 Jun; 63(3):252-61. PubMed ID: 23759528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
    Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathology of inhalational anthrax animal models.
    Twenhafel NA
    Vet Pathol; 2010 Sep; 47(5):819-30. PubMed ID: 20656900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key aspects of the molecular and cellular basis of inhalational anthrax.
    Cote CK; Welkos SL; Bozue J
    Microbes Infect; 2011 Dec; 13(14-15):1146-55. PubMed ID: 21816231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and pathophysiology of inhalational anthrax in a guinea pig model.
    Savransky V; Sanford DC; Syar E; Austin JL; Tordoff KP; Anderson MS; Stark GV; Barnewall RE; Briscoe CM; Lemiale-Biérinx L; Park S; Ionin B; Skiadopoulos MH
    Infect Immun; 2013 Apr; 81(4):1152-63. PubMed ID: 23357384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model.
    Barnewall RE; Comer JE; Miller BD; Gutting BW; Wolfe DN; Director-Myska AE; Nichols TL; Taft SC
    Front Cell Infect Microbiol; 2012; 2():71. PubMed ID: 22919662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.
    Grinberg LM; Abramova FA; Yampolskaya OV; Walker DH; Smith JH
    Mod Pathol; 2001 May; 14(5):482-95. PubMed ID: 11353060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling of murine organ genes in response to infection with Bacillus anthracis Ames spores.
    Moen ST; Yeager LA; Lawrence WS; Ponce C; Galindo CL; Garner HR; Baze WB; Suarez G; Peterson JW; Chopra AK
    Microb Pathog; 2008 Apr; 44(4):293-310. PubMed ID: 18037264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.
    Cote CK; Bozue J; Twenhafel N; Welkos SL
    J Med Microbiol; 2009 Jun; 58(Pt 6):816-825. PubMed ID: 19429760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.
    Comer JE; Ray BD; Henning LN; Stark GV; Barnewall RE; Mott JM; Meister GT
    Clin Vaccine Immunol; 2012 Sep; 19(9):1517-25. PubMed ID: 22837095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.